| Medical and Health Sciences | Lifetime | 106 | US 58 | 99.99 |
| Biological Sciences | Lifetime | 656 | US 372 | 99.92 |
| Infectious Diseases | Lifetime | 2 | US 1 | 99.99 |
| Epidemiology | Lifetime | 23 | US 14 | 99.96 |
| Clinical Biochemistry | Lifetime | 4 | US 4 | 99.89 |
| Molecular Medicine | Lifetime | 20 | US 6 | 99.54 |
| Clinical Pharmacology | Lifetime | 213 | US 92 | 99.11 |
| Applied Microbiology and Biotechnology | Lifetime | 18 | US 7 | 98.83 |
| Endocrinology | Lifetime | 172 | US 75 | 97.32 |
| Cell Biology | Lifetime | 707 | US 392 | 95.74 |
| Veterinary Science and Animal Health | Lifetime | 409 | US 140 | 95.32 |
| Emergency Medical Services | Lifetime | 578 | US 260 | 94.26 |
| Critical Care and Intensive Care Medicine | Lifetime | 376 | US 167 | 91.71 |
| Microbiology | Lifetime | 565 | US 248 | 85.47 |
| Infectious Diseases | 2021-2025 | 236 | US 91 | 95.95 |
| Antifungal resistance and susceptibility | Lifetime | 1 | US 1 | 99.99 |
| Fungal Infections and Studies | Lifetime | 1 | US 1 | 99.98 |
| Antimicrobial Resistance in Staphylococcus | Lifetime | 2 | US 2 | 99.97 |
| Pneumocystis jirovecii pneumonia detection and treatment | Lifetime | 2 | US 1 | 99.94 |
| Bacterial Identification and Susceptibility Testing | Lifetime | 2 | US 1 | 99.98 |
| Nail Diseases and Treatments | Lifetime | 2 | US 2 | 99.95 |
| Antibiotic Resistance in Bacteria | Lifetime | 12 | US 4 | 99.93 |
| Antibiotic Use and Resistance | Lifetime | 6 | US 3 | 99.92 |
| Antibiotics Pharmacokinetics and Efficacy | Lifetime | 14 | US 6 | 99.88 |
| Plant Pathogens and Fungal Diseases | Lifetime | 26 | US 8 | 99.81 |
| Infectious Diseases and Mycology | Lifetime | 8 | US 5 | 99.80 |
| Pneumonia and Respiratory Infections | Lifetime | 83 | US 39 | 99.59 |
| Streptococcal Infections and Treatments | Lifetime | 57 | US 35 | 99.45 |
| Enterobacteriaceae and Cronobacter Research | Lifetime | 17 | US 5 | 99.31 |
| Nosocomial Infections in ICU | Lifetime | 50 | US 19 | 99.39 |
| Fungal Biology and Applications | Lifetime | 148 | US 26 | 98.77 |
| Infections and bacterial resistance | Lifetime | 25 | US 7 | 98.95 |
| Bacterial biofilms and quorum sensing | Lifetime | 197 | US 74 | 98.70 |
| Infective Endocarditis Diagnosis and Management | Lifetime | 507 | US 229 | 98.06 |
| Mycotoxins in Agriculture and Food | Lifetime | 252 | US 84 | 97.81 |
| Urinary Tract Infections Management | Lifetime | 309 | US 158 | 97.83 |
| Mycobacterium research and diagnosis | Lifetime | 662 | US 213 | 97.07 |
| Essential Oils and Antimicrobial Activity | Lifetime | 761 | US 70 | 97.44 |
| Helminth infection and control | Lifetime | 277 | US 59 | 97.50 |
| Neutropenia and Cancer Infections | Lifetime | 388 | US 184 | 96.74 |
| Respiratory and Cough-Related Research | Lifetime | 697 | US 230 | 96.44 |
| Central Venous Catheters and Hemodialysis | Lifetime | 749 | US 339 | 95.48 |
| Ocular Infections and Treatments | Lifetime | 457 | US 221 | 95.24 |
| Herbal Medicine Research Studies | Lifetime | 160 | US 46 | 92.12 |
| Yeasts and Rust Fungi Studies | Lifetime | 571 | US 182 | 93.14 |
| Diphtheria, Corynebacterium, and Tetanus | Lifetime | 842 | US 274 | 78.64 |
| Beetle Biology and Toxicology Studies | Lifetime | 636 | US 141 | 53.31 |
| Antifungal resistance and susceptibility | 2021-2025 | 104 | US 30 | 97.58 |
| Fungal Infections and Studies | 2021-2025 | 77 | US 28 | 97.62 |
| Nail Diseases and Treatments | 2021-2025 | 78 | US 21 | 94.48 |
| Antibiotic Use and Resistance | 2021-2025 | 425 | US 99 | 91.92 |
| Antimicrobial Resistance in Staphylococcus | 2021-2025 | 587 | US 120 | 85.58 |
| Infectious Diseases and Mycology | 2021-2025 | 435 | US 95 | 71.96 |
